Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.36 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.36 |
| ▸ | DAO | P14920 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1031551 | 0.88 | MTNR1A (0.37) | TAAR1MAPTLMNAALDH1A1CHRM2 | |
| SCHEMBL2203418 | 0.82 | TAAR1 (0.50) | TAAR1ADRA2AADRA2BADRA2CMEN1 | |
| SCHEMBL12365048 | 0.79 | TAAR1 (0.56) | TAAR1ADRA2AADRA2BADRA2CP2RX7 | |
| SCHEMBL3339281 | 0.79 | MTNR1A (0.33) | TAAR1KMT2AALDH1A1 | |
| SCHEMBL8759222 | 0.78 | TAAR1 (0.50) | TAAR1ADRA2AADRA2BADRA2CP2RX7 | |
| SCHEMBL12585379 | 0.78 | TAAR1 (0.46) | TAAR1ADRA2AADRA2BADRA2CMEN1 | |
| SCHEMBL30081115 | 0.76 | TAAR1 (0.41) | TAAR1ADRA2AADRA2BADRA2CKMT2A | |
| SCHEMBL8759198 | 0.76 | TAAR1 (0.52) | TAAR1ADRA2AADRA2BADRA2CMEN1 | |
| SCHEMBL1639326 | 0.76 | PTGS2 (0.33) | — | |
| SCHEMBL8759213 | 0.76 | TAAR1 (0.47) | TAAR1ADRA2AADRA2BADRA2CKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12567521-B2 | Method for injecting strand-blocked cable | NOVINIUM, LLC (US) | 2026-03-03 | — | — | US | claimed |
| US-12165784-B2 | Method for injecting strand-blocked cable | NOVINIUM, LLC (US) | 2024-12-10 | — | — | US | claimed |
| US-20240266091-A1 | METHOD FOR INJECTING STRAND-BLOCKED CABLE | NOVINIUM, INC. | 2024-08-08 | — | — | US | claimed |
| US-12009119-B2 | Method for injecting strand-blocked cable | NOVINIUM, LLC (US) | 2024-06-11 | — | — | US | claimed |
| WO-2023114695-A1 | APROTIC CATALYSTS FOR THE HYDROLYSIS/CONDENSATION OF ORGANOALKOXYSILANES | NOVINIUM, LLC (US) | 2023-06-22 | — | — | WO | claimed |
| US-20230183426-A1 | APROTIC CATALYSTS FOR THE HYDROLYSIS / CONDENSATION OF ORGANOALKOXYSILANES | NOVINIUM, LLC | 2023-06-15 | — | — | US | claimed |
| EP-4115482-A1 | METHOD FOR INJECTING STRAND-BLOCKED CABLE | Novinium, Inc. (US) | 2023-01-11 | — | — | EP | claimed |
| US-20220375655-A1 | METHOD FOR INJECTING STRAND-BLOCKED CABLE | OBI PARTNERS, LLC | 2022-11-24 | — | — | US | claimed |
| CN-115322377-A | Pre-condensed power cable insulation aging repair liquid and preparation method and application thereof | 广东电网有限责任公司广州供电局 | 2022-11-11 | — | — | CN | claimed |
| WO-2021178686-A1 | METHOD FOR INJECTING STRAND-BLOCKED CABLE | NOVINIUM, INC. (US) | 2021-09-10 | — | — | WO | claimed |
| US-20210280341-A1 | METHOD FOR INJECTING STRAND-BLOCKED CABLE | OBI PARTNERS, LLC | 2021-09-09 | — | — | US | claimed |
| US-8967178-B2 | Saturation valve assembly for electric cables | UTILX CORPORATION (US) | 2015-03-03 | — | — | US | claimed |
| US-8572842-B2 | Method for thermally enhancing injection of power cables | NOVINIUM, INC. (US) | 2013-11-05 | — | — | US | claimed |
| US-20130276907-A1 | VALVE ASSEMBLY | UTILX CORPORATION (US) | 2013-10-24 | — | — | US | claimed |
| US-7976747-B2 | Method for restoring power cables | NOVINIUM, INC. (US) | 2011-07-12 | — | — | US | claimed |
| US-20100122453-A1 | THERMALLY ENHANCED POWER CABLE REJUVENATION | TECHNOLOGY RESEARCH, LLC | 2010-05-20 | — | — | US | claimed |
| US-20090133799-A1 | METHOD FOR RESTORING POWER CABLES | NOVINIUM, LLC | 2009-05-28 | — | — | US | claimed |
| US-12567521-B2 | Method for injecting strand-blocked cable | NOVINIUM, LLC (US) | 2026-03-03 | — | — | US | disclosed |
| WO-2005084321-A2 | METHOD FOR TREATING ELECTRICAL CABLE AT SUSTAINED ELEVATED PRESSURE | NOVINIUM, INC. (US) | 2005-09-15 | — | — | WO | disclosed |
| WO-2005084322-A2 | METHOD FOR SELECTING FORMULATIONS TO TREAT ELECTRICAL CABLES | NOVINIUM, INC. (US) | 2005-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12567521-B2 | Method for injecting strand-blocked cable | MMP1, POT1, TELO2 | TAAR1 1834/4885ADRA2A 2215/4885ADRA2B 1307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.